Volume 11, Number 11, November 2005

Neutralizing Antibody Response and SARS Severity

Mei-Shang Ho,* Wei-Ju Chen,* Hour-Young Chen,† Szu-Fong Lin,† Min-Chin Wang,† Jiali Di,† Yen-Ta Lu,‡ Ching-Lung Liu,‡ Shan-Chwen Chang,§ Chung-Liang Chao,¶ Chwan-Chuen King,§ Jeng-Min Chiou,* Ih-Jen Su,# and Jyh-Yuan Yang†
*Academia Sinica, Taipei, Taiwan; †Center for Disease Control, Taipei, Taiwan; ‡Taipei Mackay Memorial Hospital, Taipei, Taiwan; §National Taiwan University, Taipei, Taiwan; ¶Taipei Hospital, Taipei, Taiwan; and #National Health Research Institutes, Taipei, Taiwan

Figure 2. A) Perspective surfaces of neutralizing antibody titer (dilution) based on the fitted linear mixed model in Table 5. The median age was 36 years for men (left panel) and for women (right panel). B) Cross-sectional curves of neutralizing antibody titer (dilution) extracted from panel A with duration of illness set at 10, 17, 24, and 31 days, respectively, for men (left panel) and women (right panel); the vertical lines mark peak titer times.

EID Home | Top of Page | Ahead-of-Print | Past Issues | Suggested Citation | EID Search | Contact Us | Accessibility | Privacy Policy Notice | CDC Home | CDC Search | Health Topics A-Z

This page last reviewed October 14, 2005

Emerging Infectious Diseases Journal
National Center for Infectious Diseases
Centers for Disease Control and Prevention